Pluri Inc. Stockholders' Equity Note, Subscriptions Receivable
Pluri Inc. (PLUR) had Stockholders' Equity Note, Subscriptions Receivable of $39.84 million as of 2021-12-31, per its 10-Q filed 2022-02-07.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquityNoteSubscriptionsReceivable · last filed 2022-02-07
- 2021-12-31: Stockholders' Equity Note, Subscriptions Receivable $39.84M.
- 2021-09-30: Stockholders' Equity Note, Subscriptions Receivable $48.91M.
- 2021-06-30: Stockholders' Equity Note, Subscriptions Receivable $57.15M.
- 2021-03-31: Stockholders' Equity Note, Subscriptions Receivable $68.14M.
| Period end | Stockholders' Equity Note, Subscriptions Receivable |
|---|---|
| 2021-12-31 | $39.84M 10-Q · filed 2022-02-07 |
| 2021-09-30 | $48.91M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $57.15M 10-K · filed 2021-09-13 |
| 2021-03-31 | $68.14M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $41.15M 10-Q · filed 2021-02-08 |
| 2020-09-30 | $48.95M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $56.10M 10-K · filed 2020-09-10 |
| 2020-03-31 | $14.17M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $15.91M 10-Q · filed 2020-02-06 |
| 2019-09-30 | $17.53M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $21.82M 10-K · filed 2019-09-12 |
| 2018-06-30 | $28.51M 10-K · filed 2019-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |